Company intelligence / Profile preview

STEMCELL Technologies

Vancouver, British Columbia, Canadastemcell.com ↗

Ownership: Private
Employees: ~2300
Development stage: Other

Overview

STEMCELL Technologies does not have clinical results as it does not develop therapeutics. Its products enable basic and translational life science research globally.

Modalities: Cell therapyBiologicSmall molecule (as part of contract assay services)Recombinant protein (growth factors, cytokines)Monoclonal antibody (reagents)Organoid-based assays
Industry: Non-Drug Biotech

Partnerships

Collaborates with academic institutions and serves over 120 pharma/biotech/government/academic clients via CRO services

Beyond the preview

Go deeper on STEMCELL Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STEMCELL Technologies.